Tracer library / [153Sm]Sm-HA
[153Sm]Sm-HA
Also written as [153Sm]Sm-HA
- Radionuclide
- Sm-153
- Modality
- —
- Production route
- —
- Stage
- Approved
- Syntheses indexed
- 0
What it is
- Compound class
- Radiolabelled hydroxyapatite particulate/colloid
- Target / mechanism
- —
- Clinical application
- Radiosynovectomy for inflammatory joint disease, including haemophilic knee synovectomy PMID 20525452
- Theranostic pair
- —
Published syntheses
No synthesis has been parsed for this agent yet.
Clinical literature
Clinical studies in the indexed corpus, ordered by design (multicentre, prospective, retrospective, others, case reports last) and then by year. Titles and links only, as published; this is not a summary of the evidence.
- Comparison of the effect of knee synovectomy in haemophilic patients with 153Sm- and 90Y-labelled hydroxyapatite 1 year after.2014 · Haemophilia · Clinical study
Need this precursor?We can point you to suppliers for [153Sm]Sm-HA, or handle the enquiry for you.
Get in touchNotes
Added at stage 39 (2026-09-27) from a reverse search of the PubMed corpus's own unattached articles (articles that named a real compound not yet in this reference): 2 article(s) found under this name, not yet individually researched. Target/mechanism, clinical application, indications, approval, modality, stage and production route are intentionally left empty. PMIDs: 20525452, 24861578. Stage set/updated at stage 39 from PMID 20525452: '(153)Sm-HA is already available for nuclear medicine procedures'.